No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
ZBIO Zenas BioPharma
- 10.010
- +0.250+2.56%
Close Dec 20 16:00 ET
- 10.030
- +0.020+0.20%
Post 17:17 ET
418.33MMarket Cap-3.24P/E (TTM)
10.379High9.310Low3.63MVolume9.710Open9.760Pre Close36.26MTurnover30.91%Turnover RatioLossP/E (Static)41.79MShares26.25152wk High1.16P/B117.72MFloat Cap8.33052wk Low--Dividend TTM11.76MShs Float26.251Historical High--Div YieldTTM10.95%Amplitude8.330Historical Low9.976Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
This Addus HomeCare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
H.C. Wainwright Initiates Zenas BioPharma(ZBIO.US) With Buy Rating, Announces Target Price $30
Visa To Rally Over 20%? Here Are 10 Top Analyst Forecasts For Wednesday
Zenas BioPharma Is Maintained at Overweight by Morgan Stanley
Morgan Stanley Maintains Zenas BioPharma(ZBIO.US) With Buy Rating, Cuts Target Price to $35
Express News | Zenas Biopharma Inc : Morgan Stanley Cuts Target Price to $35.00 From $40.00
Heat List
US
Overall
Symbol
Price
% Chg
No Data
